Study to Evaluate the Safety of Intravenous Oritavancin for the Treatment of Children With Skin Infections

PHASE2RecruitingINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

June 15, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

January 15, 2026

Conditions
Acute Bacterial Skin and Skin Structure Infection
Interventions
DRUG

Orbactiv

Solution for IV infusion

DRUG

Kimyrsa

Solution for IV infusion

Trial Locations (29)

1606

RECRUITING

University Multiprofile Hospital for Active Treatment and Emergency Medicine N. I. Pirogov EAD, Sofia

3600

RECRUITING

Multiprofile Hospital for Active Treatment- Sveti Nikolay Chudotvoretz - LOM EOOD, Lom

4000

RECRUITING

University Multiprofile Hospital for Active Treatment Sveti Georgi EAD-66 Peshtersko Shosse blvd, Plovdiv

5300

RECRUITING

Multiprofile Hospital For Active Treatment Dr Tota Venkova, Gabrovo

6003

RECRUITING

University Multiprofile Hospital for Active Treatment - Prof. Dr. Stoyan Kirkovich AD, Stara Zagora

7002

RECRUITING

University Multiprofile Hospital For Active Treatment Kanev AD, Rousse

8035

RECRUITING

Hospital Universitario Vall d'Hebron - PPDS, Barcelona

8950

RECRUITING

Hospital Sant Joan de Deu - PIN, Barcelona

28041

RECRUITING

Hospital Universitario 12 de Octubre, Madrid

28046

RECRUITING

Hospital Universitario La Paz - PPDS, Madrid

33606

RECRUITING

Tampa General Hospital, Tampa

56429

RECRUITING

Papageorgiou General Hospital of Thessaloniki, Thessaloniki

92140

RECRUITING

Klaipeda Children Hospital, Klaipėda

300011

RECRUITING

Louis Turcanu Emergency Clinical Hospital for Children, Timișoara

500063

RECRUITING

Brasov Children Clinical Hospital, Brasov

10003-2925

WITHDRAWN

Mount Sinai Beth Israel, New York

43205-2664

RECRUITING

Nationwide Children's Hospital, Columbus

115 27

WITHDRAWN

Aghia Sophia' Children's General Hospital of Athens, Athens

124 62

RECRUITING

Attikon University General Hospital, Chaïdári

546 42

RECRUITING

Hippokratio General Hospital of Thessaloniki, Thessaloniki

LV-5417

RECRUITING

Daugavpils Regional Hospital, Daugavpils

LV-3414

WITHDRAWN

Regional Hospital of Liepaja, Liepāja

LV-1004

RECRUITING

Children's Clinical University Hospital, Riga

LT-50009

RECRUITING

Hospital of Lithuanian University of Health Sciences Kauno klinikos, Kaunas

04-736

WITHDRAWN

Instytut Pomnik Centrum Zdrowia Dziecka - PIN, Warsaw

2755-009

RECRUITING

Hospital de Cascais, Alcabideche

4710-243

WITHDRAWN

Hospital de Braga, Braga

1449-005

RECRUITING

Centro Hospitalar de Lisboa Ocidental, EPE - Hospital São Francisco Xavier, Lisbon

1998-018

WITHDRAWN

Hospital CUF Descobertas, Lisbon

Sponsors
All Listed Sponsors
lead

Melinta Therapeutics, LLC

INDUSTRY

NCT05599295 - Study to Evaluate the Safety of Intravenous Oritavancin for the Treatment of Children With Skin Infections | Biotech Hunter | Biotech Hunter